About Bausch Health Companies

Bausch Health (NYSE:BHC) is a diverse healthcare company engaged in developing, manufacturing, and marketing a wide range of pharmaceutical, medical device, and over-the-counter products. Its operations span across several therapeutic areas including eye health, gastroenterology, and dermatology, aiming to improve people’s lives with its products. The company is dedicated to advancing its portfolio through innovative treatments and accessible healthcare solutions. Bausch Health's objective encompasses a commitment to enhancing patient care while strategically growing its global presence through research and development, as well as partnerships and acquisitions.

Snapshot

Public USOwnership

1959Year founded

2471Employees

Laval, CanadaHead office

Loading Map...

Global footprint

Operations

All Locations

Laval, CA

Products and/or services of Bausch Health Companies

Lumify (brimonidine tartrate) eye drops provide reduction of redness to help eyes appear whiter and brighter.
Lotemax (loteprednol etabonate) is a corticosteroid for eye inflammation and pain treatment.
Xifaxan (rifaximin) is indicated for irritable bowel syndrome with diarrhea and hepatic encephalopathy.
Duobrii (halobetasol propionate and tazarotene) lotion treats plaque psoriasis in adults.
Elidel (pimecrolimus) cream is used for the treatment of atopic dermatitis (eczema) to relieve skin inflammation and itching.

Bausch Health Companies executive team

Mr. Thomas J. AppioCEO & Director
Mr. Jean-Jacques CharhonExecutive VP & CFO
Ms. Seana CarsonExecutive VP & General Counsel
Ms. Aimee J. LenarExecutive Vice President of US Pharma
Mr. Mirza DautbegovicExecutive VP & COO
Mr. Steven LeeSenior VP, Controller & Chief Accounting Officer
Mr. Garen SarafianVP & Head of Investor Relations
Ms. Kathleen FitzpatrickExecutive VP and Chief HR & Communications Officer
Mr. Cees HeimanSenior Vice President of Europe & Canada
Ms. Jiny Kim M.B.A.Senior Vice President of Solta Medical